bioecon 会员专区
供应商 · 生产商 · 发现——同类成熟企业

EID Parry India Ltd

EID Parry是糖业的领导者,在营养保健品领域占有重要地位,现进入快速消费品(FMCG)板块。凭借Parry's Consumer Products,我们正转型为一家综合性食品、营养和生物能源企业。依托235年的丰厚传承和赢得的家庭信任,我们推出了高端小米、豆类和大米系列,以“更好的谷物,更好的健康”为承诺,无缝融入消费者的日常生活。 公司在南印度拥有六家糖厂,日压榨能力40,800吨,发电140兆瓦,并拥有五家蒸馏厂,产能582 KLPD。在电力和蒸馏板块,公司不断取得重大进展——扩大各厂蒸馏产能并最大化乙醇产量,以抓住乙醇掺混计划的机遇。公司还通过子公司Coromandel International Limited在农资业务领域占有重要地位。EID Parry全资持有Parry Sugars Refinery India Private Limited和美国的US …

运营中 印度亚洲 已上市员工: 2500+ (farmer partners) and 225+ years industry experience and 12+ plants; exact employee count not clearly specified in provided sources 营收: INR 7,055 Crore (FY 2025-26) 核实于 2026-10-05

简介

E.I.D. – Parry (India) Limited is a listed Murugappa Group company headquartered at “Dare House” in Chennai that manufactures sweetness and nutraceuticals and is expanding into Consumer Products/FMCG. Founded in 1788, it operates six sugar plants (total crushing capacity ~40,800 TCD), co-generation of 140 MW, and distillery capacity ~582 KLPD; it also makes microalgae nutraceuticals (Spirulina) at plants in Tamil Nadu. It holds a 100% stake in Parry Sugars Refinery India Pvt. Ltd and US Nutraceuticals Inc. Funding/investors: market cap was ~₹16,551 Cr (10 Feb 2026). FY25 consolidated revenue from operations was ~₹7,523 Cr; employees: 2,384 (Mar 31, 2025). Latest 2025–26: the company is active (Q4 FY26 investor materials) and continues portfolio reshaping; it decided to exit the Parry Sugars & Refinery business, and launched/expanded Consumer Products (incl. rice/millets/dals beyond sugar).

Sources#

行业
生物炼制, 能源, 食品配料, 水务
主题
维生素、类胡萝卜素与保健活性成分, 糖、棕榈油与农产品加工, 生物乙醇, 微藻(螺旋藻、小球藻、裸藻)
角色
生产商 — “…Dare House” in Chennai that manufactures sweetness and nutraceuticals and is expanding into Consumer Products/…”
母公司 / 集团
Murugappa Group
为何属于生物经济
EID Parry India Ltd 是成熟的上市制糖-食品-生物能源企业(甜味剂、营养/保健品及乙醇/热电联产),并通过消费产品事业部扩展至快消品。
发现途径
Angel Yeast 安琪酵母 (SSE 600298); Godavari Biorefineries (NSE); Balrampur Chini Mills (NSE); Shree Renuka Sugars (NSE)

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

子公司: Parry Sugars Refinery India Private Limited · US Nutraceuticals Inc. (Valensa International)

新闻与状态 6

关系网络:股东、合作伙伴、同类

股权与投资方 4

母公司Murugappa Group
投资方Murugappa Group
子公司Parry Sugars Refinery India Private Limited
子公司US Nutraceuticals Inc

合作与交易 5

交易对手Parry Sugars Refinery India Private Limited (subsidiary)
…The company decided to exit and close the operations of its wholly owned subsidiary, Parry Sugars Refinery India Private Limited, effective March 31, 2026.…
合资企业Parry’s sugar
…areas: sugar products (Parry’s sugar), nutraceuticals (including Parry Nutraceuticals and joint ventures with Synthite), and related bio-based products. Core business lines include: - Sugar an…
合资企业Division focusing on microalgae-based products
…Nutraceuticals: Division focusing on microalgae-based products and other nutraceuticals; joint venture with Synthite Industries Ltd to expand capabilities in this space. - Bio pesticides and r…
合作Nutraceuticals development
…lated sweeteners. - Nutraceuticals development, including microalgae-based products, with strategic partnerships (e.g., Synthite). - Commitment to food safety and process excellence, evidenced by TPM ……
合作D. Parry (E
…cals and bio-based product development, leveraging its heritage, large group backing, and strategic partnerships to drive growth in sweeteners, … - ** ** — E.I.D. Parry (E.I.D. – Parry (India) ……

同类企业

COFCO Corporation · Mitr Phol Group · Simbhaoli Sugars Limited · PT Indofood Sukses Makmur Tbk · Fraser & Neave Holdings Bhd (F&N) · Universal Robina Corporation · 統一企業 Uni-President Enterprises Corp. · Kaset Thai International Sugar Corporation Public Co Ltd

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录